Scan how First Solar's patent play fits into the wider renewables race by lining it up against a curated 43 power grid technology and infrastructure stocks.
To own First Solar, you need to believe this manufacturer can keep turning its thin film technology, CuRe rollout, and large contracted backlog into steady module shipments while managing cost friction. The TOPCon lawsuit sits alongside that story rather than in front of it. The most important near term swing factor still appears to be how effectively management fills and redirects Malaysia and Vietnam capacity.
Underutilization at those overseas plants and higher U.S. freight expenses remain the biggest operational overhang. The new patent case may add legal costs, but it does not clearly change that core risk. In practical terms, it suggests that First Solar is relying on intellectual property to protect efficiency advantages and potential licensing income without altering the existing production roadmap.
With no new operational announcements tied directly to this lawsuit, the most relevant existing development remains the CuRe technology rollout across Series 6 and 7 through the first half of 2028. That program supports expectations for performance based adjuster revenue that clusters in 2027 and 2028. It also ties back to why First Solar is protective of efficiency related IP in court.
For you as a shareholder, the link is straightforward. CuRe execution and the roughly 45.1 GW contracted backlog provide the main visibility on volumes and margins. Legal actions around TOPCon relate to safeguarding that broader technology edge rather than replacing those drivers. The key watch points remain utilization, U.S. trade rules, and on time delivery of the CuRe roadmap.
First Solar's narrative projects US$6.9b revenue and US$3.0b earnings by 2029. This assumes 8.5% yearly revenue growth and an earnings increase of about US$1.3b from US$1.7b today.
Uncover why First Solar's fair value indicates a 53% potential upside to its current price, which could narrow quickly.
For a very different angle, focus on how bullish analysts treat First Solar's patent portfolio as a potential earnings lever rather than a cost risk. Before this lawsuit, the most optimistic forecasts already pencilled in about US$7.5b revenue and US$4.4b earnings by 2029. You can assume those views might shift as the TOPCon case unfolds, so it is worth comparing several narratives before deciding how you feel about the stock.
Explore 6 other First Solar fair value estimates, including one that suggests as much as 106% potential upside from the current price.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If the First Solar story has sharpened your thinking, broaden your watchlist by scanning other stocks that match specific qualities using the Simply Wall St Screener.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com